Menu

AdityaBirlaCapital

Aditya Birla Capital Q2 FY26: Lending Momentum Accelerates, but Profit Expansion Stays Mild

Aditya Birla Capital Q2 FY26: Lending Momentum Accelerates, but Profit Expansion Stays Mild

Aditya Birla Capital Q2 FY26: Lending Momentum Accelerates, but Profit Expansion Stays Mild

Aditya Birla Capital delivered a quarter of steady growth, led by strong momentum in lending and asset-growth businesses, while consolidated profit expansion remained modest. Revenue rose 4 % YoY to ₹12,481 crore, and PAT increased 3 % YoY to ₹855 crore. The NBFC and housing-finance portfolios grew materially (AUM up ~22-29 % YoY), while fee-income businesses (AMC, insurance) also posted healthy traction. Asset-quality remains under control (Gross Stage 2+3 at 3.03 % in lending). The business is scaling, but margin and profit lever remain mild.

*Key highlights*
* Consolidated Revenue: ₹12,481 crore (+4 % YoY)
* Consolidated Profit After Tax: ₹855 crore (+3 % YoY)
* Total Lending Portfolio (NBFC + HFC): ₹1,77,855 crore as on 30 Sept 2025 (+29 % YoY, +7 % QoQ)
* NBFC Disbursements: ₹21,990 crore (+14 % YoY, +39 % QoQ)
* NBFC AUM: ₹1,39,585 crore (+22 % YoY, +6 % QoQ)
* NBFC PBT: ₹956 crore (+13 % YoY, +3 % QoQ) & RoA 2.20%
* Gross Stage 2 + Stage 3 Ratio (lending): 3.03% (improved 121 bps YoY, 67 bps QoQ)
* Mutual Fund Quarterly Average AUM (QAAUM): ₹4,25,171 crore (+11 % YoY)
* Life Insurance Individual First Year Premium (H1 FY26): ₹1,880 crore (+19 % YoY)
* Health Insurance Gross Written Premium (H1 FY26): ₹2,839 crore (+31 % YoY)

*Revenue & profit analysis*
Revenue grew 4 % year-on-year to ₹12,481 crore, signalling steady scale. However, profit growth was only 3 % to ₹855 crore, meaning margin and cost pressures are limiting sharper bottom-line expansion.
On the lending front, while AUM and disbursements expanded strongly, profit gains are modest: the NBFC business delivered PBT ₹956 crore (up 13 % YoY) and RoA of 2.20%. That suggests the book growth is positive, but returns are still moderate given the scale.
Profit expansion is constrained likely by a mix of factors: rising cost of funds, investments in growth/ distribution and margin compression in newer segments. The modest 3% PAT growth despite healthy topline growth signals the need to monitor operating leverage and margins carefully.

*Segment performance*
* Lending/ NBFC & HFC: Disbursements ₹21,990 crore (14% YoY, 39% QoQ) and AUM ₹1,39,585 crore (22% YoY) highlight strong momentum. The housing-finance business did even better. Disbursements ₹5,786 crore (+44% YoY), AUM ₹38,270 crore (+65% YoY). Asset quality metrics improved (Stage 2+3 ratio 1.10% for HFC) indicating credit strength.
* Asset Management: The mutual fund business delivered an 11% YoY QAAUM growth to ₹4,25,171 crore. Folios serviced exceeded 1 crore (+5% YoY). Operating profit grew 13% YoY to ₹270 crore.
* Life Insurance: Individual first-year premium (FYP) in H1 rose 19% YoY to ₹1,880 crore. Market share in individual FYP rose 50 bps to 4.9%. Renewal premium grew 18% YoY to ₹4,664 crore, 13th-month persistency held at 86%.
* Health Insurance: Gross written premium up 31% YoY to ₹2,839 crore, stand-alone health insurer market share improved to 13.6% and combined ratio improved to 112%.

*Asset quality/ risk metrics*
For the lending business, the gross Stage 2+3 ratio improved to 3.03% (down 121 bps YoY, 67 bps QoQ). A RoA of 2.2% in the NBFC segment is respectable for scale-up businesses. In the HFC segment, the Stage 2+3 ratio was 1.1% (down 112 bps YoY) with RoA at 1.82% and RoE 13.95% in Q2. These figures suggest management is maintaining discipline in underwriting even while growing aggressively.

*Balance sheet & capital position*
On a standalone basis, ABCL posted PAT of ₹916 crore in Q2 FY26 (up ~12% YoY). Tier 1 ratio of 15.39% and total CRAR 17.98%. Return on equity was 14.2%. The lending portfolio across NBFC and HFC stands at ₹1,77,855 crore (+29% YoY). Total AUM (AMC + life + health) stood at ₹5,50,240 crore (+10% YoY) as on September 30, 2025. The company added 22 new branches, increasing its network to 1,712. Capital adequacy appears healthy and the company is investing in growth, which may moderate near-term margins but sustains long-term scalability.

*Management Commentary & Outlook*
Management emphasised that the quarter reflects “strong growth momentum and market share gains” in lending, insurance and funds businesses. The D2C and B2B platforms (76 lakh+ customers for ABCD, Udyog Plus AUM ₹4,397 crore) continue to expand the ecosystem. They believe that operating leverage will kick-in as investments made in distribution, data and digital mature. However, they cautioned that margin enhancement and cost discipline will be key to translating scale into stronger profits (credit cost is expected in the range ~1.2-1.3% for FY26). The company remains focused on deepening penetration into Tier 3/4 markets, continuing branch expansion.

*Conclusion*
Aditya Birla Capital has delivered a mixed but promising quarter. On one side, the business is firing on most cylinders: strong lending growth, expanding AUM, improved asset-quality and solid traction in fee-income verticals. On the other, the modest 3% PAT growth shows that scaling up is still absorbing costs and margin gains are yet to fully play out.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Ambuja Cements Q2 FY26: Volume & Margin Drive Deliver a Strong Surge

Bharti Airtel Stock Hits Fresh 52-Week High on Strong Market Momentum

Aditya Birla Capital Hits 52-Week High Amid Strong Market Momentum

Aditya Birla Capital Hits 52-Week High Amid Strong Market Momentum

Aditya Birla Capital Limited (ABCL) has captured market attention after its stock surged to a new 52-week high on the National Stock Exchange (NSE). On June 17, 2025, the company’s share price touched ₹259.30, driven by consistent bullish sentiment and increased investor confidence. This significant milestone reflects the market’s optimistic outlook towards the company’s financial health and growth prospects.

Technical Indicators Signal Bullish Breakout

The stock’s recent movement has shown strong technical support, indicating a bullish breakout pattern. Aditya Birla Capital’s share price has not only crossed its previous resistance levels but is also trading well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This multi-level support signals a sustained uptrend.

Technical experts highlight that the Relative Strength Index (RSI) currently ranges between 60 to 75, which shows that the stock has healthy momentum but is not yet in the overbought zone. In addition, recent trading sessions have seen a notable increase in volume, further confirming the strength behind the stock’s rally. Analysts suggest that immediate targets now lie at ₹309 and ₹342, with key support expected around ₹233 to ₹242.

Strong Quarterly and Annual Financial Performance

Aditya Birla Capital’s recent financial results have supported this bullish momentum. For the quarter ending March 2025, the company reported impressive revenue of ₹12,214 crore along with a net profit of ₹691 crore. On an annual basis, the company achieved a revenue of ₹40,590 crore and posted a net profit of ₹2,993 crore for the fiscal year 2025.

These figures mark a noticeable improvement from the previous fiscal year. In March 2024, the company reported revenue of ₹34,506 crore with a net profit of ₹3,135 crore. Although the profit slightly dipped on a year-on-year basis, the improvement in revenue and steady operational growth have reinforced investor trust.

The company’s book value per share also improved from ₹110 in the previous year to ₹116 in the latest fiscal period, indicating stronger asset backing for shareholders.

Valuation Metrics and Financial Ratios

Aditya Birla Capital’s financial ratios reflect a stable and well-rounded financial position. As of March 2025, the company’s Return on Equity (RoE) stands at 10.96%, while the Return on Capital Employed (ROCE) is steady. The company’s debt-to-equity ratio is currently around 4.59, showing high leverage, but this is typical in financial services and lending businesses.

The stock is currently trading at a Price-to-Earnings (P/E) ratio of 14.46 and a Price-to-Book (P/B) ratio of 1.59, suggesting that the stock is moderately valued compared to the sector. However, some analysts point out that the rising stock price may lead to an increase in valuation levels if the rally continues.

Robust Technical and Fundamental Setup

The stock’s bullish setup is further supported by key technical patterns, including a confirmed breakout from a falling wedge and the formation of bullish candles over consecutive trading sessions. The stock’s price has comfortably breached its 52-week high, supported by rising trading volumes and strong investor participation.

Year-to-date, Aditya Birla Capital’s stock has gained nearly 40%, significantly outperforming broader market indices which have posted modest gains of around 5% during the same period. This strong relative performance highlights the company’s leadership position in the financial services sector.

Potential Risks and Cautionary Notes

Despite the strong rally, investors should approach with caution. The stock’s elevated Price-to-Earnings ratio suggests that further price appreciation may depend heavily on continued earnings growth. Moreover, the company’s relatively high debt level could pose risks if macroeconomic conditions change or if interest rates rise in the future.

There is also a possibility of profit booking in the near term, especially after the recent sharp uptrend. Analysts recommend keeping a close watch on support levels between ₹233 and ₹242 to safeguard positions against potential downside corrections.

Future Outlook: Bullish with Disciplined Approach

Looking ahead, Aditya Birla Capital is expected to maintain its growth momentum driven by expanding assets under management, increasing loan disbursements, and improving asset quality. The company is well-positioned to benefit from India’s strong credit demand and favorable interest rate environment.

While the medium to long-term outlook remains positive, market experts advise investors to adopt a disciplined approach with defined entry points and strict stop-loss levels. With near-term targets set at ₹309 and ₹342, the stock offers attractive potential, provided investors manage risks carefully.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Pharma Stocks Decline Sharply Amid Fresh US Tariff Concerns